Virtus ETF Advisers LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$62,818
-36.4%
3,045
-9.1%
0.04%
-35.6%
Q2 2023$98,829
+30.3%
3,349
+1.7%
0.06%
+40.5%
Q1 2023$75,871
-40.1%
3,293
-27.7%
0.04%
-36.4%
Q4 2022$126,591
-15.6%
4,552
-6.6%
0.07%
+10.0%
Q3 2022$150,000
+5.6%
4,875
+0.7%
0.06%
+13.2%
Q2 2022$142,000
+29.1%
4,839
+41.0%
0.05%
+8.2%
Q1 2022$110,000
-32.1%
3,433
-5.5%
0.05%
-19.7%
Q4 2021$162,000
+13.3%
3,633
+28.4%
0.06%
-3.2%
Q3 2021$143,000
-38.9%
2,830
-5.0%
0.06%
-34.4%
Q2 2021$234,000
+12.5%
2,980
-18.2%
0.10%
+9.1%
Q1 2021$208,000
-30.7%
3,644
+1.6%
0.09%
-29.6%
Q4 2020$300,000
-32.9%
3,586
-71.2%
0.12%
-46.6%
Q3 2020$447,000
+30.3%
12,464
-12.1%
0.23%
+44.4%
Q2 2020$343,000
+3.0%
14,174
-25.5%
0.16%
+18.2%
Q1 2020$333,000
-12.4%
19,020
-12.8%
0.14%
+121.0%
Q4 2019$380,000
+83.6%
21,805
+61.6%
0.06%
+47.6%
Q3 2019$207,000
-30.1%
13,494
-5.3%
0.04%
-32.3%
Q2 2019$296,000
-3.6%
14,246
+7.9%
0.06%
-90.5%
Q1 2019$307,000
+0.3%
13,201
-10.7%
0.65%
+1155.8%
Q4 2018$306,000
-45.3%
14,790
-42.5%
0.05%
-10.3%
Q3 2018$559,000
-17.8%
25,718
-42.4%
0.06%
-90.3%
Q2 2018$680,00044,6170.60%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders